Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010579 |
---|---|
Receipt number | R000012338 |
Scientific Title | Phase 2 study of neoadjuvant tri-weekly Nab-paclitaxel and Trastuzumab followed by FEC(5-FU/epirubicin/cyclophosphamide) in patients for HER2 positive breast cancer. |
Date of disclosure of the study information | 2013/04/30 |
Last modified on | 2013/04/21 13:18:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/04/24 00:04:09 |